<DOC>
	<DOCNO>NCT00129532</DOCNO>
	<brief_summary>Heterosexual contact primary route transmission HIV worldwide . This study phase 3 trial design determine effectiveness safety 1.0 % C31G ( SAVVY ) vaginal gel prevention male-to-female transmission HIV among woman high risk .</brief_summary>
	<brief_title>Trial SAVVY HIV Ghana</brief_title>
	<detailed_description>Heterosexual contact primary route transmission HIV worldwide . This study phase 3 multi-center , fully-masked , randomize , placebo control trial design determine effectiveness safety 1.0 % C31G ( SAVVY ) vaginal gel prevention male-to-female transmission HIV among woman high risk .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>18 35 year old woman HIV negative More one sexual partner past 3 month Average 3 coital act per week Willing use vaginal gel condom 12 month HIV positive Pregnant</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>HIV transmission</keyword>
</DOC>